SANARA MEDTECH INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$28M↑+4.7%3.8%
2025-09-30$26M↑+21.5%$-30M↓-964.2%11.2%
2025-06-30$26M↑+28.1%$-2M↑+42.8%-0.1%
2025-03-31$23M↑+26.4%$-4M↓-96.1%-8.9%
2024-12-31$26M↑+48.7%1.8%
2024-09-30$22M↑+35.2%$-3M↓-169.5%3.6%
2024-06-30$20M↑+28.0%$-4M↓-89.1%-14.3%
2024-03-31$19M↑+19.4%$-2M↓-47.9%-8.3%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$28M
↑+4.7% +$1M YoY
Net Income
$702K

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 62 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+1.7pts
93.2%
Operating Margin↑+2.0pts
3.8%
Net Margin↓-102.3pts
-115.5%

Go deeper